KARO BIO AB | 0,01 Euro | +0,006 +150 % | |
| WKN: 913089 ISIN: SE0000571416 Ticker-Symbol: KA6 | Frankfurt | 22.05.13 | 09:03 Uhr |
Branche BiotechnologieAktienmarkt Sonstige |
|
| Zeit | Aktuelle Nachrichten
Sprache: | Leser | Medien | |
|---|---|---|---|---|
| 07.05. | Annual General Meeting 2013 in Karo Bio AB | 45 | Business Wire | |
| Regulatory News: At today's Annual General Meeting in Karo Bio (STO:KARO) the following main resolutions were passed. The AGM voted in favour of adopting the income statements... Mehr lesen zu: Annual General Meeting 2013 in Karo Bio AB | ||||
| 07.05. | Karo Bio: INTERIM REPORT JANUARY-MARCH 2013 | 66 | Business Wire | |
| Regulatory News: The January–March period 2013 in brief Net sales amounted to MSEK 8.1 (8.3) Net loss for the group was MSEK 10.7 (54.0) Loss per share was SEK... Mehr lesen zu: Karo Bio: INTERIM REPORT JANUARY-MARCH 2013 | ||||
| 30.04. | Karo Bio: Nomination Committee's Proposals to the Annual General Meeting 2013 | 20 | Business Wire | |
| Regulatory News: The nomination committee for Karo Bio AB (publ) (STO:KARO) today informed the company about its proposals to the annual general meeting. Ahead of the annual... Mehr lesen zu: Karo Bio: Nomination Committee's Proposals to the Annual General Meeting 2013 | ||||
| 15.04. | Karo Bio Publishes Annual Report | 39 | Business Wire | |
| Regulatory News: Karo Bio's (STO:KARO) Annual Report 2012 has been published and is available on the company's website www.karobio.se. Karo Bio is a development company without products... Mehr lesen zu: Karo Bio Publishes Annual Report | ||||
| 04.04. | NOTICE OF ANNUAL GENERAL MEETING IN KARO BIO AB (PUBL) | 36 | Business Wire | |
| Regulatory News: Karo Bio AB (publ)(STO:KARO): Shareholders in Karo Bio AB (publ) are hereby called to the annual general meeting on May 7, 2013 at 4.00 p.m. in the Lecture... Mehr lesen zu: NOTICE OF ANNUAL GENERAL MEETING IN KARO BIO AB (PUBL) | ||||
| 15.03. | Nominating Committee Appointed in Karo Bio AB | 46 | Business Wire | |
| Regulatory News:
Karo Bio AB (publ). As changes in ownership structure could be expected
upon completion of the right issue last year, the Board has considered... Mehr lesen zu: Nominating Committee Appointed in Karo Bio AB | ||||
| 12.02. | Karo Bio: Year-End Report January-December 2012 | 61 | Business Wire | |
| Regulatory News:
Karo Bio: (STO:KARO)
The January–December period and the fourth quarter 2012 in brief
• Net sales increased... Mehr lesen zu: Karo Bio: Year-End Report January-December 2012 | ||||
| 31.01. | Change of the Number of Shares and Votes in Karo Bio | 61 | Business Wire | |
| Regulatory News:
Karo Bio AB (publ) (STO:KARO) today announced that the company's total
number of shares as per January 31, 2013 amounts to 495,947,369 shares... Mehr lesen zu: Change of the Number of Shares and Votes in Karo Bio | ||||
| 10.01. | NASDAQ OMX Stockholm AB: Delisting of paid subscription shares in Karo Bio AB (publ) (6/13) | 258 | GlobeNewswire | |
| The paid subscription shares in Karo Bio AB (publ) will be delisted. Last
trading day will be Friday, January 11, 2013.
Instrument: Paid subscription shares
---------------------------------------
Short... Mehr lesen zu: NASDAQ OMX Stockholm AB: Delisting of paid subscription shares in Karo Bio AB (publ) (6/13) | ||||
| 18.12. | Rights Issue in Karo Bio Completed | 70 | Business Wire | |
| Regulatory News:
Karo Bio (STO:KARO):
Not for release, publication or distribution, directly or indirectly, in
or into the United States... Mehr lesen zu: Rights Issue in Karo Bio Completed | ||||
| 26.11. | NASDAQ OMX Stockholm AB: Listing of subscription rights and paid subscription shares in Karo Bio AB (97/12) | 89 | GlobeNewswire | |
| With effect from November 28, 2012, the subscription rights in Karo Bio AB will
be quoted on the list for Equity rights. Quotation will continue up until and
including December 7, 2012.
Instrument:... Mehr lesen zu: NASDAQ OMX Stockholm AB: Listing of subscription rights and paid subscription shares in Karo Bio AB (97/12) | ||||
| 26.11. | Karo Bio Announces Prospectus for the Rights Issue | 84 | Business Wire | |
| Not for release, publication or distribution, directly or indirectly, in
or into the United States, Australia, Canada, Hong Kong, Japan, New
Zeeland, Singapore, South... Mehr lesen zu: Karo Bio Announces Prospectus for the Rights Issue | ||||
| 21.11. | XFRA CAPITAL ADJUSTMENT INFORMATION - 22.11.2012 - 1 | 63 | Xetra Newsboard | |
| FOLGENDE WERTPAPIERE WERDEN AM 21.11.2012 CUM KAPITALMASSNAHME UND AM
22.11.2012 EX KAPITALMASSNAHME GEHANDELT.
THE FOLLOWING SHARES ARE TRADED CUM CAPITAL ADJUSTMENT ON 21.11.2012
AND EX CAPITAL... Mehr lesen zu: XFRA CAPITAL ADJUSTMENT INFORMATION - 22.11.2012 - 1 | ||||
| 19.11. | Karo Bio: Extraordinary General Meeting Resolved on Preferential Rights Issue | 78 | Business Wire | |
| Regulatory News:
Karo Bio AB (publ)(STO:KARO):
Not for release, publication or distribution, directly or indirectly, in
or into the United... Mehr lesen zu: Karo Bio: Extraordinary General Meeting Resolved on Preferential Rights Issue | ||||
| 19.11. | Karo Bio: Update on texas application | 84 | Business Wire | |
| Regulatory News:
Karo Bio AB (publ)(STO:KARO) has decided to supplement its grant
application in the state of Texas for the development of a drug
candidate... Mehr lesen zu: Karo Bio: Update on texas application | ||||
| 24.10. | Karo Bio Announces Rights Issue of MSEK 38.7 and Calls an Extraordinary General Meeting | 55 | Business Wire | |
| Regulatory News:
Not for release, or for publication or distribution, directly or
indirectly, in or into the United States, Australia, Canada, Hong Kong,
... Mehr lesen zu: Karo Bio Announces Rights Issue of MSEK 38.7 and Calls an Extraordinary General Meeting | ||||
| 24.10. | Karo Bio: Interim Report January–September 2012 | 27 | Business Wire | |
| Regulatory News:
Karo Bio: (STO:KARO)
The January-September period and the third quarter 2012 in brief
· Net sales increased... Mehr lesen zu: Karo Bio: Interim Report January–September 2012 | ||||
| 09.08. | CEO Buys Shares in Karo Bio | 46 | Business Wire | |
| Regulatory News:
Karo Bio's (STO:KARO) CEO, Per Bengtsson, has bought 250 000 Karo Bio
shares.
Per Bengtsson, CEO of Karo Bio AB (publ)... Mehr lesen zu: CEO Buys Shares in Karo Bio | ||||
| 13.07. | Karo Bio: INTERIM REPORT JANUARY–JUNE 2012 | 57 | Business Wire | |
| Regulatory News:
Karo Bio: (STO:KARO)
Cost reductions reach full impact in year's second half
· Net sales increased to MSEK... Mehr lesen zu: Karo Bio: INTERIM REPORT JANUARY–JUNE 2012 | ||||
| 13.06. | Karo Bio Annual General Meeting | 50 | Business Wire | |
| Regulatory News:
Karo Bio (STO:KARO):
At Karo Bio AB's annual general meeting on Tuesday June 12th, 2012, the
following was resolved.
... Mehr lesen zu: Karo Bio Annual General Meeting | ||||
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten |
|---|---|---|---|
| FARMATIC BIOTECH ENERGY | 0,006 | +20 % | XFRA FRA:Deletion of Instruments from XETRA - 04.12.2012-001 |
| GENEREX BIOTECHNOLOGY | 0,029 | +3,57 % | Generex Announces ASCO Presentations on the Antigen Express Advanced Stage AE37 Cancer Vaccine |
| DYAX | 1,933 | +0,99 % | Biotech Industry Soars in 2012 as FDA Drug Approvals Reach a 15-Year High / RDInvesting Provides Stocks Research on Neuralstem and Dyax |
| EPIGENOMICS | 1,661 | -6,16 % | Epigenomics AG: Ergebnisse der Vergleichsstudie zwischen Epigenomics Epi proColon(R) und FIT werden auf der Digestive Disease Week vorgestellt |
| COLUMBIA LABORATORIES | 0,469 | +0,21 % | COLUMBIA LABORATORIES INC - S-8, Securities to be offered to employees in employee benefit plans |
